Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City

Código QR

Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City

Jaime D Martinez,1 Anat Galor,2,3 Nallely Ramos-Betancourt,1 Andrés Lisker-Cervantes,1 Francisco Beltrán,1 Jorge Ozorno-Zárate,1 Valeria Sánchez-Huerta,1 Marco-Antonio Torres-Vera,1 Everardo Hernández-Quintela1 1Cornea and External Diseases Ser...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Martinez JD, Galor A, Ramos-Betancourt N, Lisker-Cervantes A, Beltrán F, Ozorno-Zárate J, Sánchez-Huerta V, Torres-Vera MA, Hernández-Quintela E
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	dry eye meibomian gland dysfunction ocular surface disease Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/1416466fba304252b050c500439a5689
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
por: Amano S, et al.
Publicado: (2017)

Influence of bacterial burden on meibomian gland dysfunction and ocular surface disease
por: Nattis A, et al.
Publicado: (2019)

Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction
por: Dell SJ, et al.
Publicado: (2017)

TearCare® system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare® treatment on subjects with dry eye disease
por: Badawi D
Publicado: (2019)

Meibomian Gland Morphology Changes After Cataract Surgery: A Contra-Lateral Eye Study
por: Pingjun Chang, et al.
Publicado: (2021)

Intense pulsed light for evaporative dry eye disease
por: Dell SJ
Publicado: (2017)

A novel system, TearCare®, for the treatment of the signs and symptoms of dry eye disease
por: Badawi D
Publicado: (2018)

Safety and Efficacy of BroadBand Intense Pulsed Light Therapy for Dry Eye Disease with Meibomian Gland Dysfunction
por: Murtaza F, et al.
Publicado: (2021)

The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye
por: Blackie CA, et al.
Publicado: (2016)

Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients
por: Kim MJ, et al.
Publicado: (2017)

Improved Dry Eye Symptoms and Signs of Patients With Meibomian Gland Dysfunction by a Dietary Supplement
por: Kangcheng Liu, et al.
Publicado: (2021)

Effects of Intense Pulsed Light on Tear Film TGF-β and Microbiome in Ocular Rosacea with Dry Eye
por: Sagaser S, et al.
Publicado: (2021)

Impact of Thermal Pulsation Treatment on Astigmatism Management and Outcomes in Meibomian Gland Dysfunction Patients Undergoing Cataract Surgery
por: Matossian C
Publicado: (2020)

Satisfaction and convenience of using terpenoid-impregnated eyelid wipes and teaching method in people without blepharitis
por: Qiu TY, et al.
Publicado: (2018)

Intraductal meibomian gland probing: background, patient selection, procedure, and perspectives
por: Maskin SL, et al.
Publicado: (2019)

A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease
por: Karpecki P, et al.
Publicado: (2020)

Visible Meibomian Gland Structure Increases After Vectored Thermal Pulsation Treatment in Dry Eye Disease Patients with Meibomian Gland Dysfunction
por: Hura AS, et al.
Publicado: (2020)

Effectiveness and Safety of Combined Application of Three Modes of 2940-nm Erbium:YAG and 1064-nm Neodymium:YAG Lasers in Treatment of Meibomian Gland Dysfunction
por: Kasetsuwan N, et al.
Publicado: (2021)

Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction
por: Hagen KB, et al.
Publicado: (2018)

Combined Intense Pulsed Light and Low-Level Light Therapy for the Treatment of Dry Eye: A Retrospective Before–After Study with One-Year Follow-Up
por: Pérez-Silguero MA, et al.
Publicado: (2021)

Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease
por: Qiaoxing Liang, et al.
Publicado: (2021)

A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction
por: Oleñik A, et al.
Publicado: (2013)

Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
por: Fogagnolo P, et al.
Publicado: (2020)

Comparison of the iLUX and the LipiFlow for the Treatment of Meibomian Gland Dysfunction and Symptoms: A Randomized Clinical Trial
por: Tauber J, et al.
Publicado: (2020)

The Association Between Risk Factors for Metabolic Syndrome and Meibomian Gland Disease in a Dry Eye Cohort
por: Mussi N, et al.
Publicado: (2021)

Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction
por: Stonecipher K, et al.
Publicado: (2019)

Influence of eyelid pigmentation on the diagnosis of meibomian gland dysfunction
por: Blumberg MJ, et al.
Publicado: (2019)

A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day
por: Blackie CA, et al.
Publicado: (2018)

Eye-related neoplasms in dogs: a retrospective study
por: Julián D. Muñoz-Duque, et al.
Publicado: (2019)

Meibomian Gland Morphology Among Patients Presenting for Refractive Surgery Evaluation
por: Brooks CC, et al.
Publicado: (2021)

Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial
por: Yeu E, et al.
Publicado: (2020)

Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
por: Silverstein S, et al.
Publicado: (2020)

Tear lipid layer thickness with eye drops in meibomian gland dysfunction
por: Fogt JS, et al.
Publicado: (2016)

Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
por: McDonald MB, et al.
Publicado: (2018)

Patient-reported severity of dry eye and quality of life in diabetes
por: Yazdani-Ibn-Taz MK, et al.
Publicado: (2019)

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
por: Taylor M, et al.
Publicado: (2019)

Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
por: Groß D, et al.
Publicado: (2017)

Evaluation of Meibomian Gland Dysfunction Among Ophthalmic Healthcare Workers
por: Chan AYY, et al.
Publicado: (2021)

Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
por: Pepose JS, et al.
Publicado: (2019)

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
por: White DE, et al.
Publicado: (2020)